Home > Income Statement > CONCORD BIOTECH

CONCORD BIOTECH
Revenue

    Back to Income Statement
CONCORD BIOTECH is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for CONCORD BIOTECH
Please provide your vote to see the results

CONCORD BIOTECH Last 5 Year Revenue History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Net Sales ₹1,055 Cr₹1,200 Cr₹1,017 Cr₹853 Cr₹713 Cr

What is the latest Revenue of CONCORD BIOTECH ?

The latest Revenue ratio of CONCORD BIOTECH is ₹1,055 Cr based on Mar2026 Consolidated results.
Year Revenue
Mar2026₹1,055 Cr
Mar2025₹1,200 Cr
Mar2024₹1,017 Cr
Mar2023₹853 Cr
Mar2022₹713 Cr

How is Revenue of CONCORD BIOTECH Trending?

Years Revenue % Change
Mar2026 ₹1,055 Cr
-12.10
Mar2025 ₹1,200 Cr
18.01
Mar2024 ₹1,017 Cr
19.20
Mar2023 ₹853 Cr
19.67
Mar2022 ₹713 Cr -

Compare Revenue of peers of CONCORD BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CONCORD BIOTECH ₹13,261.7 Cr -8.2% -15.1% -15.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,684.0 Cr -0.2% -4.9% 5.5% Stock Analytics
DIVIS LABORATORIES ₹242,904.0 Cr 1.3% -2.3% 38.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹172,213.0 Cr -1.5% -5.8% 29.3% Stock Analytics
CIPLA ₹106,138.0 Cr 0.1% -4.2% -14.3% Stock Analytics
DR REDDYS LABORATORIES ₹103,304.0 Cr 1.9% 5.7% 0.4% Stock Analytics


CONCORD BIOTECH Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
CONCORD BIOTECH

-8.2%

-15.1%

-15.4%

SENSEX

0.9%

-0.8%

-10.5%


You may also like the below Video Courses